Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mendes

Showing results (31-40 of 473) with videos related to

Pageof 48
Sort By:
Pharmacy Practice|January 3, 2017
Analysis of ten years of publishing in Pharmacy PracticeAntonio E Mendes, Fernanda S Tonin, Fernando Fernandez-Llimos
World Journal of Experimental Medicine|March 7, 2017
Comments on eurytrematosis in Brazil and the possibility of human infectionClaiton I Schwertz, Luan C Henker, Ricardo E Mendes
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 2, 2014
Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanismsRodrigo E Mendes, Lalitagauri M Deshpande, Ronald N Jones
International Journal of Antimicrobial Agents|July 6, 2010
Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007-2008)Rodrigo E Mendes, Helio S Sader, Ronald N Jones
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 20, 2021
Antimicrobial activity of dalbavancin and comparators against Staphylococcus aureus causing pneumonia in patients with and without cystic fibrosisHelio S Sader, Leonard R Duncan, Rodrigo E Mendes
Diagnostic Microbiology and Infectious Disease|September 25, 2020
Update on the in vitro activity of dalbavancin against indicated species (Staphylococcus aureus, Enterococcus faecalis, β-hemolytic streptococci, and Streptococcus anginosus group) collected from United States hospitals in 2017-2019Helio S Sader, Jennifer M Streit, Rodrigo E Mendes
Journal of Clinical Microbiology|June 13, 2014
Quality control MIC ranges used for telavancin with application of a revised CLSI reference broth microdilution methodJames E Ross, Rodrigo E Mendes, Ronald N Jones
Antimicrobial Agents and Chemotherapy|March 23, 2016
Dalbavancin Activity When Tested against Streptococcus pneumoniae Isolated in Medical Centers on Six Continents (2011 to 2014)Ronald N Jones, Jason E Schuchert, Rodrigo E Mendes
Mycopathologia|July 1, 1989
Ketoconazole resistance in Torulopsis glabrataG Nobre, E Mendes, M J Charrua, et al.
Antimicrobial Agents and Chemotherapy|January 22, 2015
Antimicrobial activity of solithromycin against serotyped macrolide-resistant Streptococcus pneumoniae isolates collected from U.S. medical centers in 2012D J Farrell, R E Mendes, R N Jones
Pageof 48

Showing results (31-40 of 473) with videos related to

Sort By:
Pageof 48
Pharmacy Practice|January 3, 2017
Analysis of ten years of publishing in Pharmacy PracticeAntonio E Mendes, Fernanda S Tonin, Fernando Fernandez-Llimos
World Journal of Experimental Medicine|March 7, 2017
Comments on eurytrematosis in Brazil and the possibility of human infectionClaiton I Schwertz, Luan C Henker, Ricardo E Mendes
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 2, 2014
Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanismsRodrigo E Mendes, Lalitagauri M Deshpande, Ronald N Jones
International Journal of Antimicrobial Agents|July 6, 2010
Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007-2008)Rodrigo E Mendes, Helio S Sader, Ronald N Jones
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 20, 2021
Antimicrobial activity of dalbavancin and comparators against Staphylococcus aureus causing pneumonia in patients with and without cystic fibrosisHelio S Sader, Leonard R Duncan, Rodrigo E Mendes
Diagnostic Microbiology and Infectious Disease|September 25, 2020
Update on the in vitro activity of dalbavancin against indicated species (Staphylococcus aureus, Enterococcus faecalis, β-hemolytic streptococci, and Streptococcus anginosus group) collected from United States hospitals in 2017-2019Helio S Sader, Jennifer M Streit, Rodrigo E Mendes
Journal of Clinical Microbiology|June 13, 2014
Quality control MIC ranges used for telavancin with application of a revised CLSI reference broth microdilution methodJames E Ross, Rodrigo E Mendes, Ronald N Jones
Antimicrobial Agents and Chemotherapy|March 23, 2016
Dalbavancin Activity When Tested against Streptococcus pneumoniae Isolated in Medical Centers on Six Continents (2011 to 2014)Ronald N Jones, Jason E Schuchert, Rodrigo E Mendes
Mycopathologia|July 1, 1989
Ketoconazole resistance in Torulopsis glabrataG Nobre, E Mendes, M J Charrua, et al.
Antimicrobial Agents and Chemotherapy|January 22, 2015
Antimicrobial activity of solithromycin against serotyped macrolide-resistant Streptococcus pneumoniae isolates collected from U.S. medical centers in 2012D J Farrell, R E Mendes, R N Jones
Pageof 48